title: Effects of oligomycin on transient currents carried by Na+ translocation of Bufo Na+/K(+)-ATPase expressed in Xenopus oocytes.
abstract: Na(+)/K(+)-ATPase (NKA) exports 3Na(+) and imports 2K(+) at the expense of the hydrolysis of 1ATP under physiological conditions. In the absence of K(+), it can mediate electroneutral Na(+)/Na(+) exchange. In the electroneutral Na(+)/Na(+) exchange mode, NKA produces a transient current containing fast, medium and slow components in response to a sudden voltage step. These three components of the transient current demonstrate the sequential release of Na(+) ions from three binding sites. Our data from oocytes provide further experimental support for the existence of these components. Oligomycin is an NKA inhibitor that favors the 2Na(+)-occluded state without affecting the conformational state of the NKA. We studied the effects of oligomycin on both K(+)-activated currents and transient currents in wild-type Bufo NKA and a mutant form of Bufo NKA, NKA: G813A. Oligomycin blocked almost all of the K(+)-activated current, although the three components of the transient current showed different sensitivities to oligomycin. The oligomycin-inhibited charge movement measured using a P/4 protocol had a rate coefficient similar to the medium transient component. The fast component of the transient current elicited by a short voltage step also showed sensitivity to oligomycin. However, the slow component was not totally inhibited by oligomycin. Our results indicate that the second and third sodium ions might be released to the extracellular medium by a mechanism that is not shared by the first sodium ion.
authors.affiliation: Department of Biological Sciences, Ohio University, Athens, OH 45701, USA. yding5@partners.org
authors.forename: Yanli
authors.initials: Y
authors.lastname: Ding
authors.forename: Jingping
authors.initials: J
authors.lastname: Hao
authors.forename: Robert F
authors.initials: RF
authors.lastname: Rakowski
mesh_terms: D000818:Animals; D002024:Bufo marinus; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015640:Ion Channel Gating / Q000187:drug effects / Q000235:genetics; D017136:Ion Transport / Q000187:drug effects; D009154:Mutation; D009840:Oligomycins / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects* / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D014982:Xenopus laevis
chemical_list: D004791:Enzyme Inhibitors; D009840:Oligomycins; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase